InnovAge Holding Corp.

PACE — Program of All-Inclusive Care for the Elderly — is a Medicare and Medicaid program where providers assume full financial risk for participants' total care. InnovAge receives a per-member per-month payment from CMS and state Medicaid agencies, then covers all medical, social, and long-term care costs for each enrolled senior. The model only works when the provider can keep participants healthy enough to avoid expensive hospitalizations, so InnovAge invests heavily in preventive care and center-based medical coordination.

Major capital allocation decisions — new center construction, market exits, and real estate commitments — are made by CEO Patrick Blair and the company's board, which includes representatives from its former private equity sponsor and current institutional shareholders. After its 2021 SPAC merger, InnovAge operates as a publicly traded company with fiduciary duties to shareholders, not a single-family allocator with unlimited discretion.

A 2021 CMS audit found deficiencies in how those centers documented participant care, assessed medical needs, and provided certain contracted services. The enrollment freeze lasted until late 2022 for Sacramento; San Francisco remained under heightened monitoring. During this period, InnovAge could not add new participants at these facilities, directly capping revenue growth at two of its highest-cost markets.

Each PACE center is a lease- or ownership-heavy commitment combining adult day centers, primary care clinics, therapy spaces, and transportation infrastructure in a single building. The real estate is not a passive investment — it directly enables the care delivery that generates per-member revenue. When a center fails to maintain census, fixed real estate costs become a direct drag on margins.

InnovAge is a publicly traded healthcare operator that manages government-reimbursed care for frail seniors. It is not, and has never been described as, a family office. Its listing followed a 2021 SPAC merger; prior to that, it was backed by private equity firm Welsh, Carson, Anderson & Stowe and a handful of institutional investors, but the entity itself always operated as a direct service provider rather than a private capital allocator.

InnovAge exited Florida entirely in 2023, selling its single Tampa center to concentrate capital on its established Western and Mid-Atlantic clusters. The firm has not entered new states since the 2021 CMS sanctions, instead building additional capacity within Colorado and California where it already holds operating licenses and Medicare contracts.

The PACE per-member rate is set by federal and state governments and is not commercially negotiated, giving payers unilateral rate-setting authority. If CMS lowers the rate or adjusts risk-adjustment formulas unfavorably, InnovAge's revenue per participant drops immediately — there is no renegotiation window. That makes the firm's cost-structure discipline and center efficiency the only levers to protect margins during rate cycles.